What is ArriVent BioPharma, Inc. Common Stock's Market Cap?

ArriVent BioPharma, Inc. Common Stock's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.

What is ArriVent BioPharma, Inc. Common Stock's Enterprise Value?

ArriVent BioPharma, Inc. Common Stock's Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is ArriVent BioPharma, Inc. Common Stock's Net Income (TTM)?

ArriVent BioPharma, Inc. Common Stock's Net Income (TTM) is -$163.7M, based on as-reported figures from SEC (XBRL) filings.

What is ArriVent BioPharma, Inc. Common Stock's Diluted EPS (TTM)?

ArriVent BioPharma, Inc. Common Stock's Diluted EPS (TTM) is -3.32, based on as-reported figures from SEC (XBRL) filings.

What is ArriVent BioPharma, Inc. Common Stock's Net Debt?

ArriVent BioPharma, Inc. Common Stock's Net Debt is -$373.1M, based on as-reported figures from SEC (XBRL) filings.

ArriVent BioPharma, Inc. Common Stock (AVBP) Financial Statements

ArriVent BioPharma, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG011N37VW3

XNAS · usd

30.34▲ 0.06 (0.20%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close30.28

Day's Range30.02 – 31.40

52-Week Range17.00 – 35.83

Volume721.6K

Avg Volume420.1K

Share Statistics

Shares Outstanding

Employees77

ExchangeXNAS

Listed2024-01-26

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about ArriVent BioPharma, Inc. Common Stock (AVBP)

What is ArriVent BioPharma, Inc. Common Stock's Market Cap?: ArriVent BioPharma, Inc. Common Stock's Market Cap is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is ArriVent BioPharma, Inc. Common Stock's Enterprise Value?: ArriVent BioPharma, Inc. Common Stock's Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is ArriVent BioPharma, Inc. Common Stock's Net Income (TTM)?: ArriVent BioPharma, Inc. Common Stock's Net Income (TTM) is -$163.7M, based on as-reported figures from SEC (XBRL) filings.
What is ArriVent BioPharma, Inc. Common Stock's Diluted EPS (TTM)?: ArriVent BioPharma, Inc. Common Stock's Diluted EPS (TTM) is -3.32, based on as-reported figures from SEC (XBRL) filings.
What is ArriVent BioPharma, Inc. Common Stock's Net Debt?: ArriVent BioPharma, Inc. Common Stock's Net Debt is -$373.1M, based on as-reported figures from SEC (XBRL) filings.